Phase II Trial of Irinotecan, Carboplatin, and Bevacizumab in the Treatment of Patients with Extensive-Stage Small-Cell Lung Cancer
2009 ◽
Vol 4
(12)
◽
pp. 1555-1560
◽
Keyword(s):
Phase Ii
◽
2011 ◽
Vol 6
(6)
◽
pp. 1117-1120
◽